| 1 |
[GO] |
2024―Okt―23 |
Role of CT-based body composition parameters in the course of COVID-19 |
ELÇİN AYDIN, BEGÜM ERGİN, EZGİ GÜVEL VERDİ, ÖZGE COŞKUN, ŞÜKRÜ ŞAHİN, ALİ HAYDAR BAYKAN, HİLAL ŞAHİN |
| 2 |
[GO] |
2024―Okt―23 |
Evaluation with structural equation modeling of variables affecting health-seeking behaviors during the COVID-19 pandemic in İstanbul, Türkiye |
PINAR ATALI, SEYHAN HIDIROĞLU, ALİCAN SARISALTIK, MELDA KARAVUŞ |
| 3 |
[GO] |
2024―Sep―03 |
Relationship between functional status and fatigue after COVID-19 infection: a multicenter study from Türkiye |
İPEK CANDEMİR, PINAR ERGÜN, DİCLE KAYMAZ, MUSTAFA ENGİN ŞAHİN, İPEK ÖZMEN, ELİF YILDIRIM, ASLI GÖREK DİLEKTAŞLI, BÜŞRA YİĞİTLİLER, AYTEN ODABAŞ, DENİZ KIZILIRMAK, SEÇİL SARI, CELALETTİN KORKMAZ, CANTÜRK TAŞÇI, YAKUP ARSLAN, SEMA SAVCI, BUSE KAHRAMAN, AYLİN TANRIVERDİ, CAN SEVİNÇ, MELDA SAĞLAM, DENİZ İNAL İNCE, NACİYE VARDAR YAĞLI, EBRU KÜTÜKÇÜ, DİLBER DURMAZ, NESLİHAN DURUTÜRK, GAYE ULUBAY, LÜTFİYE KILIÇ, BENAN ÇAĞLAYAN, AYLİN MORAY, SABRİ SERHAN OLCAY, GÜVEN ÖZKAYA |
| 4 |
[GO] |
2024―Sep―03 |
Do patients infected with human coronavirus before the COVID-19 pandemic have less risk of being infected with COVID-19? |
GAMZE ŞANLIDAĞ İŞBİLEN, AYÇA AYDIN UYSAL, SELİN YİĞİT, ÖZGÜR APPAK, HİLAL SİPAHİ, GÜLENDAM BOZDAYI, ARZU SAYINER, CANDAN ÇİÇEK, ÖZLEM GÜZEL TUNÇCAN, OĞUZ REŞAT SİPAHİ |
| 5 |
[GO] |
2024―Jun―18 |
Comparison of radiologic findings between SARS-CoV-2 and other respiratory tract viruses in critically ill children during the COVID-19 pandemic |
OKTAY PERK, TANIL KENDİRLİ, EMEL UYAR, BİRSEL ŞEN AKOVA, HATİCE ALBAYRAK, HASAN AĞIN, EBRU ATİKE ONGUN, EŞE EDA TURANLI, SARE GÜNTÜLÜ ŞIK, ŞAHİN SİNCAR, GÜRKAN BOZAN, DEMET DEMİRKOL, NAZAN ÜLGEN TEKEREK, MEY TALİP, ARZU OTO, FEYZA İNCEKÖY GİRGİN, FERHAT SARI, NURETTİN ONUR KUTLU, ALTAN GÜNEŞ, ÖMER SUAT FİTÖZ |
| 6 |
[GO] |
2024―Feb―20 |
Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients |
Aslıhan Avanoğlu GÜLER, Büşra ÖZÇİMEN, Mesude Seda AYDOĞDU, Alper SARI, Aliyeva NUMUNE, Nazife Tüzün ERSAN, Seda ÇOLAK, Hazan KARADENİZ, İbrahim VASİ, Hamit KÜÇÜK, Yasemin YALÇINKAYA, Abdulsamet ERDEN, Mehmet KAYAALP, Mehmet Akif ÖZTÜRK, Berna GÖKER, Ahmet OMMA, Sedat YILMAZ, Süleyman Serdar KOCA, Murat İNANÇ, Ali AKDOĞAN, Abdurrahman TUFAN |
| 7 |
[GO] |
2023―Dez―17 |
COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period |
GÜLŞEN İSKENDER, DUYGU MERT, GÖKNUR YAPAR TOROS, FUNDA YILMAZ, ERSİN BOZAN, SEMRA TUNÇBİLEK, ÖMÜR BERNA ÇAKMAK ÖKSÜZOĞLU, FEVZİ ALTUNTAŞ, MUSTAFA ERTEK |
| 8 |
[GO] |
2023―Dez―17 |
Positive effects of health behaviors acquired during the COVID-19 pandemic process on the prevention of other infectious diseases |
ASİYE ÇİĞDEM ŞİMŞEK, TURAN BUZGAN, FATMA NUR BARAN AKSAKAL, ŞUAYIP BİRİNCİ, HÜLYA ŞİRİN |
| 9 |
[GO] |
2023―Okt―31 |
Alterations in B and NK cells highly correlate with disease severity in children with COVID-19 |
EZGİ TOPYILDIZ, NESLİHAN KARACA, RAZİYE BURCU TAŞKIN, AYŞE AYGÜN, ZÜMRÜT ŞAHBUDAK BAL, EYLEM ULAŞ SAZ, NURİ ZAFER KURUGÖL, NECİL KÜTÜKÇÜLER, GÜZİDE AKSU |
| 10 |
[GO] |
2023―Okt―31 |
Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome |
EMRAH ŞENEL, SEYHAN TÜRK, ÜMİT YAVUZ MALKAN, MUSTAFA ÇAĞRI PEKER, CAN TÜRK, HATİCE RAHMET GÜNER, GÜLBERK UÇAR, SEVAL İZDEŞ, BİRCAN KAYAASLAN, GÜLSÜM İCLAL BAYHAN, SERHAT EMEKSİZ, İMRAN HASANOĞLU, ŞERİFE GÖKBULUT BEKTAŞ, ŞEYMA BÜTÜN TÜRK, SERHAN ÖZCAN |
| 11 |
[GO] |
2023―Okt―31 |
Which sequence should be used in the thorax magnetic resonance imaging of COVID-19: a comparative study |
AYŞE ŞULE ATEŞ, BURAK YAĞDIRAN, ONUR TAYDAŞ, ÖMER FARUK ATEŞ |
| 12 |
[GO] |
2023―Okt―31 |
Clinical and laboratory features in health care volunteers with inactivated SARS-CoV-2 vaccination |
ZHIJIE LI, YAFANG WAN, LANLAN XU, WENJIA ZHANG, YU ZHANG, PU LIAO |
| 13 |
[GO] |
2023―Feb―24 |
COVID-19 modeling based on real geographic and population data |
EMİR BAYSAZAN, AHMET NİHAT BERKER, HASAN MANDAL, HAKAN KAYGUSUZ |
| 14 |
[GO] |
2022―Dez―23 |
COVID-19 in pediatric nephrology centers in Turkey |
EMRE LEVENTOĞLU, YEŞİM ÖZDEMİR ATİKEL, HÜLYA NALÇACIOĞLU, İSMAİL DURSUN, HASAN DURSUN, ZEYNEP NAGEHAN YÜRÜK YILDIRIM, NURDAN YILDIZ, GÜLŞAH KAYA AKSOY, MEHMET TAŞDEMİR, MEHTAP ÇELAKIL, BELTİNGE DEMİRCİOĞLU KILIÇ, ŞENAY ZIRHLI SELÇUK, NUR CANPOLAT, EVRİM KARGIN ÇAKICI, SARE GÜLFEM ÖZLÜ |
| 15 |
[GO] |
2022―Dez―23 |
A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection |
MEVLÜT TAMER DİNCER, NECMİ EREN, AHMET MURT, NURİYE YILDIZ, ŞEYDA GÜL ÖZCAN, METİN ERGÜL, SİBEL GÖKÇAY BEK, ZEYNEP ATLI, SİNAN TRABULUS, ERKAN DERVİŞOĞLU, HAMDİ LEVENT DOĞANAY, NURHAN SEYAHİ |
| 16 |
[GO] |
2022―Dez―23 |
Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination |
SERKAN İŞGÖREN, GİZEM KÖROĞLU, GÖZDE DAĞLIÖZ GÖRÜR, HAKAN DEMİR |
| 17 |
[GO] |
2022―Okt―21 |
The effect of frailty on the development of acute kidney injury in critically-ill geriatric patients with COVID-19 |
MURAT KÜÇÜK, BİŞAR ERGÜN, MEHMET NURİ YAKAR, ÖZER URAL ÇAKICI, ERDEM YAKA, BİLGİN CÖMERT, ALİ NECATİ GÖKMEN, BEGÜM ERGAN |
| 18 |
[GO] |
2022―Okt―21 |
Brain hypoxia caused by respiratory obstruction which should not be forgotten in COVID-19 disease |
ALEKSANDR URAKOV, NIKITA MUHUTDINOV, ILNUR YAGUDIN, DARYA SUNTSOVA, MILENA SVETOVA |
| 19 |
[GO] |
2022―Okt―21 |
Magnetic resonance imaging findings in COVID-19-related anosmia |
HÜSEYİN ÇETİN, AYŞE ŞULE ATEŞ, OGÜN TAYDAŞ, BAHRİ ELMAS, ERTUĞRUL GÜÇLÜ |
| 20 |
[GO] |
2022―Okt―21 |
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study |
ORHAN KÜÇÜKŞAHİN, ABDULSAMET ERDEN, ÖZLEM KARAKAŞ, SERDAR CAN GÜVEN, BERKAN ARMAĞAN, ENES SEYDA ŞAHİNER, OSMAN İNAN, ALİ CAN KURTİPEK, EMİN GEMCİOĞLU, SELMA KARAAHMETOĞLU, SEMA TURAN, SEVAL İZDEŞ, DENİZ ERDEM, ADALET AYPAK, MÜGE AYHAN |
| 21 |
[GO] |
2022―Aug―15 |
Remdesivir treatment for patients with moderate to severe COVID-19 |
İMRAN HASANOĞLU, HATİCE RAHMET GÜNER, İLHAMİ ÇELİK, FİKRET KANAT, AYŞE BATIREL, GÜLÇİN TELLİ DİZMAN, ESMA ERYILMAZ EREN, DİLEK YILDIZ SEVGİ, İLKAY BOZKURT, KADRİYE KART YAŞAR, SEVTAP ŞENOĞLU, ESRA KAZAK, RIDVAN KARAALİ, AYSEL KOCAGÜL ÇELİKBAŞ, HÜSNÜ PULLUKÇU |
| 22 |
[GO] |
2022―Aug―15 |
The role of CD8+ regulatory T cells and B cell subsets in patients with COVID-19 |
HÜLYA UÇARYILMAZ, DİLEK ERGÜN, HÜSAMETTİN VATANSEV, HANDE KÖKSAL, ONUR URAL, UĞUR ARSLAN, HASİBE ARTAÇ |
| 23 |
[GO] |
2022―Aug―15 |
COVID-19 course in granulomatosis with polyangiitis: single center experience with review of the literature |
BERKAN ARMAĞAN, MEHMET AKİF EKSİN, SERDAR CAN GÜVEN, BAHAR ÖZDEMİR, PINAR AKYÜZ DAĞLI, ORHAN KÜÇÜKŞAHİN, AHMET OMMA, ABDULSAMET ERDEN |
| 24 |
[GO] |
2022―Aug―15 |
Cross-sectional study of Middle East respiratory syndrome coronavirus in humans and dromedary camels in Diyala, Iraq |
ABDULRAZAK HASAN, KAREEM ALI, MOHAMMAD SALEH |
| 25 |
[GO] |
2022―Aug―15 |
Future pandemics: how can we be ready? |
ZEYNEP TÜRE YÜCE, EMİNE ALP MEŞE |
| 26 |
[GO] |
2022―Jul―08 |
Return visit characteristics of SARS-CoV-2 PCR-positive cases in a pediatric emergency department |
NİHAN ŞIK, DURGÜL ÖZDEMİR, MURAT DUMAN |
| 27 |
[GO] |
2022―Jul―08 |
Risk factors and prognosis in children hospitalized due to pandemic H1N1 influenza A virus infection in Ankara, Turkey* |
MEDİNE AYŞİN TAŞAR, YILDIZ BİLGE, ÖZGE UYSAL SOYER, ŞÜKRAN YILDIRIM, MUSTAFA TAŞAR, FATMA İNCİ ARIKAN |
| 28 |
[GO] |
2022―Jul―08 |
Chest radiography and computed tomography findings of cases with pandemic influenza A (H1N1/09) infection |
PINAR NERCİS KOŞAR, ZELİHA KOÇAK TUFAN, ELİF ERGÜN, HASAN YİĞİT, UĞUR KOŞAR, ALİ PEKCAN DEMİRÖZ |
| 29 |
[GO] |
2022―Jun―22 |
The clinical follow-up and management of COVID-19 in children and adolescents withan immunocompromised state or a malignancy |
İREM CEREN ERBAŞ, HATİCE KARAOĞLU ASRAK, AYŞE ÇAKIL GÜZİN, ŞİLEM ÖZDEM ALATAŞ, ŞEFİKA AKYOL, MERAL TORUN BAYRAM, REFİK EMRE ÇEÇEN, DİLEK İNCE, ÖZLEM TÜFEKÇİ, NURŞEN BELET |
| 30 |
[GO] |
2022―Jun―22 |
Turkey's transition to face-to-face schooling during the COVID-19 pandemic |
MAHMUT ÖZER, HAYRİ EREN SUNA, MATJAZ PERC, SADRİ ŞENSOY, SEVİL UYGUN İLİKHAN |
| 31 |
[GO] |
2022―Jun―22 |
The effect of COVID-19 pandemic in a large series of patients with Takayasu arteritis |
ALİ KARAKAŞ, TUBA YÜCE İNEL, FATOŞ ÖNEN, İSMAİL SARI |
| 32 |
[GO] |
2022―Jun―22 |
Determination of COVID-19 PCR positivity and mutation status in coronaVacvaccinated individuals in Turkey |
AHMET ÇALIŞKAN, MÜCAHİT SEÇME, İLKNUR KALELİ, TUĞBA SARI, SEDEF ZELİHA ÖNER, SANİYE KÜÇÜKAKIN YAKA, BÜŞRA DÖNMEZ |
| 33 |
[GO] |
2022―Jun―22 |
An evaluation of the results of convalescent plasma therapy applied to pregnant womendiagnosed as COVID-19- positive in a pandemic center: A prospective cohort study |
SEYİT AHMET EROL, ATAKAN TANAÇAN, HAKAN APAYDIN, ŞULE GÖNCÜ AYHAN, DENİZ OLUKLU, DERYA UYAN HENDEM, SERPİL ÜNLÜ, ABDULSAMET ERDEN, ÖZLEM MORALOĞLU TEKİN, AHMET OMMA, İHSAN ATEŞ, ORHAN KÜÇÜKŞAHİN, DİLEK ŞAHİN |
| 34 |
[GO] |
2022―Jun―22 |
The efficacy of anakinra compared to standard care of treatment for COVID-19: a metaanalysis |
HAMNA MALIK, HIRA BINT ABDUL JABBAR, FARAH LATIF, AZZA SARFRAZ, ZOUINA SARFRAZ, MUZNA SARFRAZ |
| 35 |
[GO] |
2022―Mai―19 |
Evaluation of the frequency and intensity of COVID-19 in patients with ankylosingspondylitis under anti-TNF therapy |
SÜMEYYE MERVE TÜRK, ZEYNEP ÖZTÜRK, DAMLA KARATAŞ, ÜNAL ERKORKMAZ, EMEL GÖNÜLLÜ |
| 36 |
[GO] |
2021―Dez―18 |
From asymptomatic to critical illness: decoding various clinical stages of COVID-19 |
İlhami ÇELİK, Recep ÖZTÜRK |
| 37 |
[GO] |
2021―Dez―18 |
Achievements of the COVID-19 Turkey Platform in vaccine and drug development with an approach of “co-creation and s쳮ding together” |
Hasan MANDAL |
| 38 |
[GO] |
2021―Nov―30 |
Immune dysfunction in COVID-19 and judicious use of anti-rheumatic drugs for the treatment of hyperinflammation |
|
| 39 |
[GO] |
2021―Nov―30 |
Epidemiology of COVID-19: What Changed in One Year? |
|
| 40 |
[GO] |
2021―Nov―12 |
EVALUATION OF THE FREQUENCY and INTENSITY OF COVID-19 IN PATIENTS WITH ANKYLOSING SPONDYLITIS UNDER ANTI-TNF THERAPY |
|
| 41 |
[GO] |
2021―Nov―12 |
Effect of Tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospecitve cohort study |
|
| 42 |
[GO] |
2021―Nov―04 |
Evaluation of Coagulation with TEG in Patients Diagnosed COVID-19 |
|
| 43 |
[GO] |
2021―Okt―19 |
SARS-COV-2 vaccine: First-month results of a six-month follow-up study |
|
| 44 |
[GO] |
2021―Okt―06 |
Magnetic Resonance Imaging Findings in COVID-19-related Anosmia: Initial Results |
|
| 45 |
[GO] |
2021―Sep―30 |
Non-pharmaceutical interventions in Turkey and worldwide during COVID-19 pandemic |
|
| 46 |
[GO] |
2021―Sep―30 |
COVID-19 and SEPSIS |
|
| 47 |
[GO] |
2021―Sep―19 |
Pregnancy and COVID-19: Prevention, Vaccination, Therapy and Beyond |
|
| 48 |
[GO] |
2021―Sep―08 |
A COVID-19 First Evaluation Clinic at a University Hospital in Turkey |
|
| 49 |
[GO] |
2021―Sep―08 |
Decrease of left ventricular ejection fraction in severe illness patients due to COVID-19 may improve as the disease resolves |
|
| 50 |
[GO] |
2021―Aug―29 |
Correlation of neuroimaging and thorax CT findings in patients with COVID-19: a large single-center experience |
|
| 51 |
[GO] |
2021―Aug―29 |
Clinical Characteristics and Risk Factors for 28-day Mortality in Critically Ill Patients with COVID-19: A Retrospective Cohort Study |
|
| 52 |
[GO] |
2021―Aug―27 |
From Asymptomatic to Critical Illness: Decoding Various Clinical Stages of COVID-19 |
|
| 53 |
[GO] |
2021―Aug―21 |
Retrospective Evaluation of Seven Different Treatment Protocols in Hospitalized COVID-19 Patients |
|
| 54 |
[GO] |
2021―Aug―16 |
From asymptomatic to critical illness different clinical manifestations of COVID-19 in Children |
|
| 55 |
[GO] |
2021―Aug―16 |
Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients |
|
| 56 |
[GO] |
2021―Aug―15 |
Evaluating the efficiency of public policy measures against COVID-19 |
|
| 57 |
[GO] |
2021―Aug―15 |
Antiviral treatment of COVID-19: An update |
|
| 58 |
[GO] |
2021―Aug―09 |
THE RADIOLOGICAL FINDINGS OF COVID-19 |
|
| 59 |
[GO] |
2021―Aug―09 |
Short-Term Economic Impact of the Covid-19 Pandemic on the Global and Turkish Economy |
|
| 60 |
[GO] |
2021―Aug―09 |
Turkey?s Response to COVID-19 Pandemic: Strategy and Key Actions |
|
| 61 |
[GO] |
2021―Aug―09 |
RNA-Based COVID-19 Vaccine Candidates with Clinical Phase Trials in Progress |
|
| 62 |
[GO] |
2021―Aug―09 |
GLOBAL HEALTH EMERGENCIES DURING THE PANDEMIC AND THEIR SOLUTIONS |
|
| 63 |
[GO] |
2021―Aug―04 |
Comparison of SARS-COV2 antibody assays in PCR negative and PCR positive Turkish patients |
|
| 64 |
[GO] |
2021―Aug―02 |
Assessment of olfactory and gustatory functions in COVID-19 patients |
|
| 65 |
[GO] |
2021―Aug―02 |
Implementation of post-intensive care outpatient clinic (I-POINT)
for critically-ill COVID-19 survivors |
|
| 66 |
[GO] |
2021―Aug―02 |
ALLERGIC REACTIONS AGAINST COVID-19 VACCINES |
|
| 67 |
[GO] |
2021―Jul―22 |
Current Infection Prevention and Control Strategies of COVID-19 in Hospitals |
|
| 68 |
[GO] |
2021―Jul―21 |
Managing life during the pandemic: Communication strategies, mental health and the ultimate toll of the COVID-19 |
|
| 69 |
[GO] |
2021―Jul―21 |
One and a half years into the COVID-19 pandemic - Exit strategies and efficacy of SARS-CoV-2 vaccines for holistic management and achieving global control |
|
| 70 |
[GO] |
2021―Jul―21 |
How efficient are facial masks against COVID-19? Evaluating the mask use of various communities one year into the pandemic |
|
| 71 |
[GO] |
2021―Jul―21 |
Pandemic Hospitals and Re-organizing Emergency Departments |
|
| 72 |
[GO] |
2021―Jul―07 |
Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity |
|
| 73 |
[GO] |
2021―Jun―27 |
Interleukin-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients |
|
| 74 |
[GO] |
2021―Jun―23 |
Effects of hydroxychloroquine and favipiravir on clinical course in outpatients with COVID-19 |
|
| 75 |
[GO] |
2021―Jun―13 |
Effect of Coronavirus Pandemic on Organ Donation and Transplantation in Turkey |
|
| 76 |
[GO] |
2021―Jun―10 |
Long-term proton pump inhibitor use is a risk factor for
mortality in patients hospitalized for COVID-19 |
|
| 77 |
[GO] |
2021―Jun―07 |
COVID-19 third wave: A challenge for overburdened and shabby healthcare system of Pakistan |
|
| 78 |
[GO] |
2021―Mai―23 |
Malignancy is a risk factor for higher COVID-19 severity:A meta-analysis |
|
| 79 |
[GO] |
2021―Mai―19 |
Galectin-3: Can It Be A Diagnostic Tool For Pneumonia In COVID-19 Patients? |
|
| 80 |
[GO] |
2021―Mai―07 |
Covid-19 Clinical Course and Blood Groups: Turkish Population-Based Study |
|
| 81 |
[GO] |
2021―Mai―07 |
Risk Factors Associated with Mortality in Intensive Care COVID-19 Patients: the importance of chest CT score and intubation timing as risk factors |
|
| 82 |
[GO] |
2021―Apr―30 |
First known COVID-19 case and contact tracing efforts in
Istanbul, Turkey |
|
| 83 |
[GO] |
2021―Apr―23 |
Pleural complications of Covid-19 pneumonia |
|
| 84 |
[GO] |
2021―Apr―21 |
Pulse Steroid Treatment for Hospitalized Adults with COVID-19 |
|
| 85 |
[GO] |
2021―Apr―21 |
The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients |
|
| 86 |
[GO] |
2021―Apr―16 |
A single center survey study of systemic vasculitis and COVID-19 during the first months of pandemic |
|
| 87 |
[GO] |
2021―Apr―12 |
Impact of COVID-19 on serum melatonin levels and sleep parameters in children |
|
| 88 |
[GO] |
2021―Mrz―28 |
Effects of the COVID-19 Pandemic on Psychology and Disease Activity in Patients with Ankylosing Spondylitis and Rheumatoid Arthritis |
|
| 89 |
[GO] |
2021―Mrz―17 |
Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department? |
|
| 90 |
[GO] |
2021―Mrz―15 |
The Comparison of Lopinavir/Ritonavir Combination and Favipiravir In COVID-19 Treatment |
|
| 91 |
[GO] |
2021―Mrz―11 |
Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic |
|
| 92 |
[GO] |
2021―Mrz―08 |
The Relationship of Extent of Initial Radiological Involvement with the Need of Intensive Care, Mortality Rates and Laboratory Parameters in COVID-19. |
|
| 93 |
[GO] |
2021―Mrz―08 |
CURRENT COMMUNITY TRANSMISSION AND FUTURE PERSPECTIVES ON THE COVID-19 PROCESS |
|
| 94 |
[GO] |
2021―Mrz―01 |
An evaluation of chest computed tomography and hemogram data in patients with COVID-19: The importance of the thymus |
|
| 95 |
[GO] |
2021―Feb―22 |
Impact of Hospital-acquired Acute Kidney Injury on Covid-19 Outcomes in Patients with and without Chronic Kidney Disease: A multicentre, retrospective cohort study |
|
| 96 |
[GO] |
2021―Feb―22 |
Preferences of Inflammatory Arthritis Patients for Biological Disease-Modifying Antirheumatic Drugs in the First 100 Days of COVID-19 Pandemic |
|
| 97 |
[GO] |
2021―Feb―14 |
SARS-CoV-2 associated rhabdomyolysis in 32 patients |
|
| 98 |
[GO] |
2021―Feb―01 |
How Safe Are Children With Covid-19 From Cardiac Risks? Pediatric Risk Assessment, insights from Echocardiography and Electrocardiography |
|
| 99 |
[GO] |
2021―Jan―12 |
The clinical impact of the COVID-19 pandemic on daily urological practice: First 3 month multicenter results from Istanbul |
|
| 100 |
[GO] |
2021―Jan―10 |
Evaluation of Systemic Involvement of Coronavirus Disease 2019 through Spleen; Size and Texture Analysis |
|
| 101 |
[GO] |
2020―Dez―22 |
Consensus Recommendations for Botulinum Toxin Injections
in the Spasticity Management of Children with Cerebral Palsy During COVID-19 Outbreak |
|
| 102 |
[GO] |
2020―Dez―14 |
Factors affecting mortality in geriatric patients hospitalized with COVID-19 |
|
| 103 |
[GO] |
2020―Dez―14 |
Influence of aluminum salts on COVID-19 infected patients |
Ali DEMİR, İbrahim ERAYMAN, Oğuz DOĞAN, Murat KEKİLLİ |
| 104 |
[GO] |
2020―Dez―14 |
The predictive and diagnostic accuracy of long Pentraxin-3 in COVID-19 Pneumonia |
|
| 105 |
[GO] |
2020―Dez―14 |
Evaluation of Initial Chest CT Findings of COVID-19 Pneumonia in 117 Deceased Patients: a Retrospective Study |
|
| 106 |
[GO] |
2020―Dez―11 |
A SENSITIVE INDICATOR FOR THE SEVERITY OF COVID-19: THIOL |
|
| 107 |
[GO] |
2020―Nov―27 |
Tocilizumab and COVID-19: A Meta-Analysis of 2120 Patients with Severe Disease and Implications for Clinical Trial Methodologies |
|
| 108 |
[GO] |
2020―Nov―25 |
Treatment of SARS-cov-2 pneumonia with favipiravir: Early results from the Ege University cohort, Turkey |
|
| 109 |
[GO] |
2020―Nov―16 |
THE IMPORTANCE OF QUALITY AND ACCREDITATION IN HEALTH CARE SERVICES IN THE PROCESS OF STRUGGLE AGAINST COVID-19 |
|
| 110 |
[GO] |
2020―Nov―13 |
Clinical course of COVID-19 disease in immunosuppressed renal transplant patients |
|
| 111 |
[GO] |
2020―Nov―13 |
Characteristics and Outcomes of Critically Ill Patients with Covid-19 in Sakarya, Turkey: A Single Center Cohort Study |
|
| 112 |
[GO] |
2020―Okt―29 |
Pre-emptive Action Saves Lives in A Pandemic: Closing the Grand Bazaar Before The Fire Of COVID-19 Infection Starts |
|
| 113 |
[GO] |
2020―Okt―20 |
A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma |
|
| 114 |
[GO] |
2020―Okt―06 |
Cerebral hemodynamic alterations in patients with Covid-19 |
|
| 115 |
[GO] |
2020―Okt―06 |
COVID-19 transmission sources, management, and scientific research in Turkey |
|
| 116 |
[GO] |
2020―Okt―02 |
Do initial hematologic indices predict the severity of COVID-19 patients? |
|
| 117 |
[GO] |
2020―Sep―20 |
Efficacy of convalescent plasma according to blood groups in COVID-19 patients. |
|
| 118 |
[GO] |
2020―Sep―20 |
Characteristics and Mortality Determinants of COVID-19 Patients Undergoing Haemodialysis |
|
| 119 |
[GO] |
2020―Aug―25 |
The impact of the "low molecular weight heparin" administration on the clinical course of COVID-19 disease |
|
| 120 |
[GO] |
2020―Aug―11 |
COVID-19 related anxiety in people living with HIV: An online cross-sectional study |
|
| 121 |
[GO] |
2020―Aug―11 |
Melatonin, Aging and COVID-19: Could melatonin be beneficial for COVID-19 treatment in elderly? |
|
| 122 |
[GO] |
2020―Jul―28 |
Perspectives for the immune plasma treatment of COVID-19 |
|
| 123 |
[GO] |
2020―Jul―28 |
Hepatitis A susceptibility parallels high COVID-19 mortality |
|
| 124 |
[GO] |
2020―Jul―28 |
Outcome of Non-Critical COVID-19 Patients with Early Hospitalization and Early Antiviral Treatment Outside the ICU |
|
| 125 |
[GO] |
2020―Jul―19 |
COVID-19 experience of the major pandemic response center in the capital: Results of the pandemic's first month in Turkey |
|
| 126 |
[GO] |
2020―Jul―19 |
The use of hydroxychloroquine plus azithromycin and early hospital admission are beneficial in Covid-19 patients: Turkey experience with real-life data |
|
| 127 |
[GO] |
2020―Jun―30 |
COVID-19 and dermatology |
|
| 128 |
[GO] |
2020―Jun―30 |
The factors predicting pneumonia in COVID-19 patients: preliminary results of a university hospital in Turkey |
|
| 129 |
[GO] |
2020―Jun―12 |
Projecting the Course of COVID-19 in Turkey: A Probabilistic Modeling Approach |
|
| 130 |
[GO] |
2020―Jun―09 |
COVID-19: Pathogenesis, genetic polymorphism, flinical features and laboratory findings |
|
| 131 |
[GO] |
2020―Jun―04 |
The effects of blood group types on the risk of COVID-19 infection and its clinical outcome |
|
| 132 |
[GO] |
2020―Mai―31 |
Letter to the Editor: Radiological approaches to COVID-19 pneumonia |
|
| 133 |
[GO] |
2020―Mai―31 |
Response to letter to the editor:
radiological approaches to COVID-19 pneumonia |
|
| 134 |
[GO] |
2020―Mai―31 |
Characteristics of the initial patients hospitalized for COVID-19: a single-center report |
|
| 135 |
[GO] |
2020―Mai―18 |
Is there relationship between SARS-CoV 2 and the complement C3 and C4? |
|
| 136 |
[GO] |
2020―Mai―12 |
Chest CT features of the novel coronavirus disease (COVID-19) |
|
| 137 |
[GO] |
2020―Apr―30 |
The usual course of thorax CT findings of Covid-19 infection and
when should control thorax CT scan? |
|
| 138 |
[GO] |
2020―Apr―30 |
Gynecological laparoscopic surgery in the shade of COVID-19 pandemic |
|
| 139 |
[GO] |
2020―Apr―18 |
Novel coronavirus disease (COVID-19) in children |
Hasan TEZER, Tuğba BEDİR DEMİRDAĞ |
| 140 |
[GO] |
2020―Apr―18 |
COVID-19 outbreak control, example of ministry of health of Turkey |
Yasemin DEMİRBİLEK, Gülen PEHLİVANTÜRK, Zeynep Özge ÖZGÜLER, Emine ALP MEŞE |
| 141 |
[GO] |
2020―Apr―18 |
Mobilizing the research ecosystem for scientific advances towards positive impact in the context of the COVID-19 Pandemic |
Hasan MANDAL |
| 142 |
[GO] |
2020―Apr―18 |
Global surveillance, travel, and trade during a pandemic |
Ceren ÇETİN, Ateş KARA |
| 143 |
[GO] |
2020―Apr―17 |
Epidemiology of COVID-19 |
Cemal BULUT, Yasuyuki KATO |
| 144 |
[GO] |
2020―Apr―17 |
Protective measures for COVID-19 for healthcare providers and laboratory personnel |
Canan AĞALAR, Derya ÖZTÜRK ENGİN |
| 145 |
[GO] |
2020―Apr―17 |
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs |
Abdurrahman TUFAN, Aslıhan AVANOĞLU GÜLER, Marco MATUCCI-CERINIC |
| 146 |
[GO] |
2020―Apr―17 |
Crushing the curve, the role of national and international institutions and policy makers in COVID-19 pandemic |
Zeliha KOÇAK TUFAN, Bircan KAYAASLAN |
| 147 |
[GO] |
2020―Apr―17 |
Radiological approaches to COVID-19 pneumonia |
Şule AKÇAY, Tevfik ÖZLÜ, Aydın YILMAZ |
| 148 |
[GO] |
2020―Apr―17 |
Understanding dynamics of pandemics |
Levent AKIN, Mustafa Gökhan GÖZEL |
| 149 |
[GO] |
2020―Apr―15 |
Antiviral treatment of COVID-19 |
|
| 150 |
[GO] |
2020―Apr―15 |
Emerging and reemerging respiratory viral infections up to Covid-19 |
|
| 151 |
[GO] |
2020―Apr―15 |
Critically-ill COVID-19 patient |
|
| 152 |
[GO] |
2020―Apr―15 |
COVID-19: Prevention and control measures in community |
|
| 153 |
[GO] |
2020―Apr―15 |
Coronaviruses and SARS-CoV-2 |
|
| 154 |
[GO] |
2020―Apr―14 |
The early impact of the Covid-19 pandemic on the global and Turkish economy |
|
| 155 |
[GO] |
2020―Apr―14 |
SARS-CoV-2 epidemiology and control, different scenarios for Turkey |
|
